Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
2021 · Journal for ImmunoTherapy of Cancer · 147 citations
https://doi.org/10.1136/jitc-2021-003894
W
Won Jin Ho
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
364
Papers
4.3K
Citations
29
h-index
56
i10-index
Won Jin Ho is an academic researcher from Bloomberg (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 29, co-authored 310 publications.
ORCID: 0000-0003-2644-5086Papers by this author
worksEntinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
2024 · Nature Cancer · 42 citations
https://doi.org/10.1038/s43018-024-00729-w
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors
2025 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-025-58512-z
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
2024 · Cell Reports Medicine · 21 citations
https://doi.org/10.1016/j.xcrm.2024.101397
Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials
2022 · JCI Insight · 16 citations
https://doi.org/10.1172/jci.insight.160398
CyTOF protocol for immune monitoring of solid tumors from mouse models
2022 · STAR Protocols · 9 citations
https://doi.org/10.1016/j.xpro.2022.101949
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat